AlphAIalphai — Financial news for AI agents
SEC EDGARAUG 241 min read$AVAH

WILLIAMS ROBERT M JR sold $192.6M of AVAH (indirect holdings)

WILLIAMS ROBERT M JR sold 16,750,002 indirectly-held shares of Aveanna Healthcare Holdings, Inc. (AVAH) at $11.50 ($192.63M total) across 6 trades over 2026-08-20 to 2026-08-21.

Original reporting
SEC EDGAR · WILLIAMS ROBERT M JR
Published Aug 24, 2026, 10:25 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 24, 2026, 10:59 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
alphai market briefInsider activity
Primary signal
$AVAH
Bearish
high confidence
Mentioned
$AVAH
Relevance
8/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$AVAHBearishMed
01

Why it matters

A $192M insider sell is sizable for a mid‑cap healthcare company and can influence short‑term price dynamics.

02

Market read

The filing is a primary source of new material information that may affect AVAH's stock price in the near term.

03

What to watch

The sale was executed via multiple trades at a consistent $11.50 price, possibly indicating a pre‑arranged liquidity need rather than negative outlook.

Relevance 8/10Novelty 8/10Timing: post‑market 2026‑08‑20

Background

Form 4 filings provide the first public disclosure of insider transactions, offering timely insight into insider sentiment.

Company-level read

Ticker impact

$AVAHBearishHigh confidence
Context

10% owner Robert M. Williams Jr. sold 16.75M shares (~$192.6M) in AVAH, reducing his stake to ~12.3M shares.

Expected impact

Possible short‑term downside pressure; traders may consider defensive positions.

Evidence & confidence

The sale represents a material portion of the insider's holdings and is disclosed via a primary Form 4 filing, making it a fresh, material event.

Market effects

Sector

May raise concerns for the healthcare services sector if other insiders follow suit.

Regional

Limited to U.S. markets where AVAH trades.

Global

Minimal global impact beyond AVAH investors.

Counterpoint

What could challenge this read

Insider could be diversifying; the sale does not necessarily reflect company fundamentals.

Key entities

  • Company
    Aveanna Healthcare Holdings, Inc.

    Ticker AVAH, provider of home health and hospice services.

  • Insider
    Robert M. Williams Jr.

    10% owner of AVAH who executed the sale.

Read at source← All news

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

AVAH insider trading history →

Related articles

AUG 21
$AVAHMedAI 8/10

Aveanna Healthcare (AVAH) Just Ended A Four-Year Rate Fight

Aveanna Healthcare (AVAH) reported Q2 revenue of $670M, up 13.7% YoY, with all divisions growing. CEO Shaner announced a pediatric nursing rate increase in California starting 2027. Adjusted EBITDA rose 8% to $95.4M. The company raised full-year guidance to over $2.68B in revenue and $365M in adjusted EBITDA. However, private duty services saw higher costs per hour, and some growth was due to nonrecurring items.

insidermonkey.com3 min
AUG 21
$AVAHHighAI 8/10

Why is Aveanna Healthcare stock sliding today?

Aveanna Healthcare (AVAH) stock fell 7.6% in pre-market trading after existing shareholders, including J.H. Whitney Equity Partners and insiders, sold 15 million shares at $11.75, a discount to the prior close. The underwriter has a 30-day option to sell more shares, adding supply pressure. The company itself is not selling shares or receiving proceeds. The broader U.S. market is higher in pre-market.

investing.com2 min
AUG 20
$AVAHHighAI 9/10

Aveanna Healthcare (AVAH) Q2 2026 Earnings Call Transcript

Aveanna Healthcare (AVAH) reported Q2 2026 revenue of $670.5M, up 13.7% YoY, with adjusted EBITDA of $95.4M, up 8%. All segments grew, with Private Duty Services leading at $553.9M, up 14%. The company raised full-year revenue guidance to over $2.68B and adjusted EBITDA to over $365M. Management highlighted strategic payer alignments, acquisitions, and cost efficiencies.

fool.com3 min